p21(WAF1/Cip1) expression is associated with cell differentiation but not with p53 mutations in squamous cell carcinomas of the larynx

Journal of Pathology

Volumn 183, Issue 2, 1997, Pages 156-163

  Nadal, Alfons ^a   Jares, Pedro ^a,b   Cazorla, Maite ^a   Fernández, Pedro L ^a   Sanjuan, Xavier ^a   Hernandez, Lluis ^a   Pinyol, Magda ^a   Aldea, Martí ^b   Mallofré, Carme ^a   Muntané, Jaume ^a   Traserra, José ^a   Campo, Elías ^a,b,c   Cardesa, Antonio ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Universitat de Lleida Facultat de Medicina Sabadell   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

Differentiation; Larynx; P21(WAF1 Cip1); P53; Squamous cell carcinoma

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; MESSENGER RNA; MUTANT PROTEIN; PROTEIN P21; PROTEIN P53; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; LARYNX CARCINOMA; MALE; PRIORITY JOURNAL; PROTEIN INDUCTION; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; ENZYME IMMUNOASSAY; GENETICS; LARYNX TUMOR; METABOLISM; MIDDLE AGED; MUTATION; NORTHERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, NORTHERN; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; GENE EXPRESSION; GENES, P53; HUMANS; IMMUNOENZYME TECHNIQUES; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030612980     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199710)183:2<156::AID-PATH908>3.0.CO;2-O     Document Type: Article

References (29)

1. Nadal A, Campo E, Pinto J, et al. p53 expression in normal, dysplastic, and neoplastic laryngeal epithelium. Absence of a correlation with prognostic factors. J Pathol 1995; 175: 181-188.
2. Dolcetti R, Doglioni C, Maestro R, et al. p53 over-expression is an early event in the development of human squamous-cell carcinomas of the larynx: genetic and prognostic implications. Int J Cancer 1992; 52: 178-182.
3. Jares P, Fernandez PL, Campo E, et al. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumour progression in human laryngeal carcinomas. Cancer Res 1994; 54: 4813-4817.
4. Xiong Y, Zhang H, Beach D. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 1992; 71: 505-514.
5. El-Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor supression. Cell 1993; 75: 817-825.
6. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993; 75: 805-816.
7. Parker SB, Eichele G, Zhang P, et al. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science 1995; 267: 1024-1027.
8. Missero C, Calautti E, Eckner R, et al. Involvement of the cell-cycle inhibitor Cip1AVAF1 and the E1A-associated p300 protein in terminal differentiation. Proc Natl Acad Sci USA 1995; 92: 5451-5455.
9. Hunter T, Pines J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 1994; 79: 573-582.
10. Chen YQ, Cipriano SC, Arenkiel JM, Miller FR. Tumor suppression by p21WAF1. Cancer Res 1995; 55: 4536-4539.
11. Shiohara M, El-Deiry WS, Wada M, et al. Absence of WAF1 mutations in a variety of human malignancies. Blood 1994; 84: 3781-3784.
12. DiGiuseppe JA, Redston MS, Yeo CJ, Kern SE, Hruban RH. p53-independent expression of the cyclin-dependent kinase inhibitor p21 in pancreatic carcinoma. Am J Pathol 1995; 147: 884-888.
13. El-Deiry WS, Tokino T, Waldman T. et al. Topological control of p2IWAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res 1995; 55: 2910-2919.
14. American Joint Committee on Cancer, editors. Pharynx (Including Base of Tongue, Soft Palate, and Uvula), Larynx. Manual for Staging of Cancer. 4th edn. Philadelphia: J. B. Lippincott, 1992: 33-44.
15. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
16. Hernandez L, Fest T, Cazorla M, et al. p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. Blood 1996; 87: 3351-3359.
17. Largey JS, Meltzer SJ, Yin J, Norris K, Sauk JJ, Archibald DW. Loss of heterozygosity of p53 in oral cancers demonstrated by the polymerase chain reaction. Cancer 1993; 71: 1933-1937.
18. Nakamura Y, Ballard L, Leppert M, et al. Isolation and mapping of a polymorphic DNA sequence (pYNZ22) on chromosome 17p [D17S30]. Nucleic Acids Res 1988; 16: 5707.
19. Waf-1 in human cutaneous squamous cell carcinomas. Am J Pathol 1996; 149: 1139-1146.
20. Zhang W, Grasso L, McClain CD, et al. p53-independent induction of WAF1/Cip1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res 1995; 55: 668-674.
21. MacLeod KF, Sherry N, Hannon G, et al. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 1995; 9: 935-944.
22. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 1994; 54: 3391-3395.
23. Tomasino RM, Morello V, Bazan V, et al. p53 expression in stage III-IV squamous-cell carcinoma of the larynx: an immunohistochemical study related to clinico-pathological, flow-cytometric DNA analysis and prognosis, Int J Oncol 1994; 5: 495-500.
24. Zhang LF, Hemminki K, Szyfter K, Söderkvist P. p53 mutations in larynx cancer. Carcinogenesis 1994; 15: 2949-2951.
25. Maestro R, Dolcetti R, Gasparotto D, et al. High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Oncogene 1992; 7: 1159-1166.
26. Hartmann A, Blaszyk H, McGovern RM, et al. p53 gene mutation inside and outside of exons 5-8: the patterns differ in breast and other cancers. Oncogene 1995; 10: 681-688.
27. Kocialkowski S, Pezzella F, Morrison H, et al. Mutations in the p53 gene are not limited to classic 'hot spots' and are not predictive of p53 protein expression in high-grade non-Hodgkin's lymphoma. Br J Haematol 1995; 89: 55-60.
28. Marchetti A, Doglioni C, Barbareschi M, et al. p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation. Oncogene 1996; 12: 1319-1324.
29. Doglioni C, Pelosio P, Laurino L, et al. p21/WAF1/CIP1 expression in normal mucosa and in adenomas and adenocarcinomas of the colon: its relationship with differentiation. J Pathol 1996; 179: 248-253.